Product Categories
| Country: | United States |
|---|---|
| Tel: | |
| Mobile: | 6314854226 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Ispinesib | C30H33ClN4O2 | 336113-53-2 | Details |
| XL147 | C21H16N6O2S2 | 956958-53-5 | Details |
| GSK-3787 | C15H12ClF3N2O3S | 188591-46-0 | Details |
| ETP-46321 | C20H27N9O3S | 1252594-99-2 | Details |
| EPZ015666 | C20H25N5O3 | 1616391-65-1 | Details |
| N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide | C24H25ClFN5O3 | 439081-18-2 | Details |
| Brivanib alaninate | C22H24FN5O4 | 649735-63-7 | Details |
| Cediranib maleate | C25H27FN4O3·C4H4O4 | 857036-77-2 | Details |
| LY-900009 | C23H27N3O4 | 209984-68-9 | Details |
| AZ5104 | C27H31N7O2 | 1421373-98-9 | Details |
| SU 5205 | C15H10FNO | 3476-86-6 | Details |
| Lusutrombopag | C29H32Cl2N2O5S | 1110766-97-6 | Details |
| Methyl 2,5-dihydroxycinnamate | C10H10O4 | 63177-57-1 | Details |
| Obatoclax mesylate | C20H19N3O.CH4O3S | 803712-79-0 | Details |
| Mubritinib | C25H23F3N4O2 | 366017-09-6 | Details |
| Rostafuroxin | C23H34O4 | 156722-18-8 | Details |
| Lavendustin A | C21H19NO6 | 125697-92-9 | Details |
| Vatalanib | C20H15ClN4 | 212141-54-3 | Details |
| AZD-8931 | C23H25ClFN5O3 | 848942-61-0 | Details |
| HMN-214 | C22H20N2O5S | 173529-46-9 | Details |
| PF-04691502 | C22H27N5O4 | 1013101-36-4 | Details |
| UNC-0638 | C30H47N5O2 | 1255580-76-7 | Details |
| Icotinib hydrochloride | C22H22ClN3O4 | 1204313-51-8 | Details |
| AZD9291DA | C25H31N7O | 1421372-66-8 | Details |
| UNC-2025 | C28H40N6O | 1429881-91-3 | Details |
| Fruquintinib | C21H19N3O5 | 1194506-26-7 | Details |
| NCGC00244536 | C25H22N2O2 | 2003260-55-5 | Details |
| E7046 | C22H18F5N3O4 | 1369489-71-3 | Details |
| Zibotentan | C19H16N6O4S | 186497-07-4 | Details |
| Eltoprazine hydrochloride | C12H16N2O2.ClH | 98206-09-8 | Details |
| SU5408 | C18H18N2O3 | 15966-93-5 | Details |
| Irbinitinib | C26H24N8O2 | 937263-43-9 | Details |
| IOX2 | C19H16N2O5 | 931398-72-0 | Details |
| 17-Phenyl Trinor Prostaglandin F2α Methyl Amide | C24H35NO4 | 155206-01-2 | Details |
| AZD8186 | C24H25F2N3O4 | 1627494-13-6 | Details |
| AG-1557 | C16H14IN3O2 | 189290-58-2 | Details |
| JK-P3 | C18H17N3O3 | 942655-44-9 | Details |
| EGF816 | C26H31ClN6O2 | 1508250-71-2 | Details |
| CC-223 | C21H27N5O3 | 1228013-30-6 | Details |
| EPZ015866 | C22H28N4O2 | 1616391-87-7 | Details |
| PD123319 | C31H32N4O3 | 130663-39-7 | Details |
| Cediranib dihydrochloride | C25H27FN4O3 | 288383-20-0 | Details |
| GDC0941 | C23H27N7O3S2 | 957054-30-7 | Details |
| Darusentan | C22H22N2O6 | 171714-84-4 | Details |
| Nutlin-3b | C30H30Cl2N4O4 | 675576-97-3 | Details |
| Palosuran | C25H30N4O2 | 540769-28-6 | Details |
| CPI-444 | C20H21N7O3 | 1202402-40-1 | Details |
| (Z)-JIB-04 | C17H13ClN4 | 199596-24-2 | Details |
| Elafibranor | C22H24O4S | 923978-27-2 | Details |
| SU 4942 | C15H10BrNO | 76086-99-2 | Details |
| hVEGF-IN-1 | C34H43N7O2 | 1637443-98-1 | Details |
| KNK437 | C13H11NO4 | 218924-25-5 | Details |
| Nutlin-3 | C30H30Cl2N4O4 | 548472-68-0 | Details |
| AV-412 | C27H28ClFN6O | 451492-95-8 | Details |
| WZ-4002 | C25H27ClN6O3 | 1213269-23-8 | Details |
| Rigosertib sodium | C21H26NNaO8S | 1225497-78-8 | Details |
| GW 627368X | C30H28N2O6S | 439288-66-1 | Details |
| Copanlisib | C23H28N8O4 | 1032568-63-0 | Details |
| Regorafenib Hydrochloride | C21H16Cl2F4N4O3 | 835621-07-3 | Details |
| Regorafenib monohydrate | C21H17ClF4N4O4 | 1019206-88-2 | Details |
| Naquotinib | C30H42N8O3 | 1448232-80-1 | Details |
| CID5721353 | C15H9BrN2O6S2 | 301356-95-6 | Details |
| AG 1406 | C16H18N2O | 71308-34-4 | Details |
| AS-604850 | C11H5F2NO4S | 648449-76-7 | Details |
| Oglufanide | C16H19N3O5 | 38101-59-6 | Details |
| GlyH-101 | C19H15Br2N3O3 | 328541-79-3 | Details |
| GSK-461364 | C27H28F3N5O2S | 929095-18-1 | Details |
| GSK1059615 | C18H11N3O2S | 958852-01-2 | Details |
| Umbralisib | C31H24F3N5O3 | 1532533-67-7 | Details |
| 3-Methyltoxoflavin | C8H9N5O2 | 32502-62-8 | Details |
| MS023 | C17H25N3O | 1831110-54-3 | Details |
| MSDC-0602 | C19H17NO5S | 1133819-87-0 | Details |
| SU 5614 | C15H13ClN2O | 1055412-47-9 | Details |
| KW-2449 | C20H20N4O | 1000669-72-6 | Details |
| XL 765 | C31H29N5O6S | 1349796-36-6 | Details |
| UNC1215 | C32H43N5O2 | 1415800-43-9 | Details |
| Pilaralisib | C25H25ClN6O4S | 934526-89-3 | Details |
| Mutant EGFR inhibitor | C27H30ClN7O2 | 1421373-62-7 | Details |
| ML324 | C21H23N3O2 | 1222800-79-4 | Details |
| MDK34597 | C19H17N5O2 | 371934-59-7 | Details |
| Cloprostenol sodium | C22H30ClNaO6 | 55028-72-3 | Details |
| Selumetinib | C17H15BrClFN4O3 | 606143-52-6 | Details |
| Tivozanib | C22H19ClN4O5 | 475108-18-0 | Details |
| AC-55541 | C25H20BrN5O3 | 916170-19-9 | Details |
| Preladenant | C25H29N9O3 | 377727-87-2 | Details |
| Icotinib | C22H21N3O4 | 610798-31-7 | Details |
| EAI045 | C19H14FN3O3S | 1942114-09-1 | Details |
| WAY-100635 maleate | C29H38N4O6 | 634908-75-1 | Details |
| Semaxinib | C15H14N2O | 204005-46-9 | Details |
| Brivanib | C19H19FN4O3 | 649735-46-6 | Details |
| MLN0128 | C15H15N7O | 1224844-38-5 | Details |
| PIK 75 hydrochloride | C16H15BrClN5O4S | 372196-77-5 | Details |
| CL-387785 | C18H13BrN4O | 194423-06-8 | Details |
| AT-406 | C32H43N5O4 | 1071992-99-8 | Details |
| CNX-2006 | C26H27F4N7O2 | 1375465-09-0 | Details |
| SM-164 | C62H84N14O6 | 957135-43-2 | Details |
| VPS34-IN1 | C21H24ClN7O | 1383716-33-3 | Details |
| 3-Methyladenine | C6H7N5 | 5142-23-4 | Details |
| GDC-0084 | C18H22N8O2 | 1382979-44-3 | Details |
| IMR-1A | C13H11NO5S2 | 331862-41-0 | Details |
| Product Total： Product Page： | ||||
| 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 | ||||